← Back to Search

Behavioural Intervention

Project EVO Multi- Treatment for Systemic Lupus Erythematosus

N/A
Waitlist Available
Research Sponsored by National Jewish Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of SLE
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights

Study Summary

The purpose of this study is to evaluate whether a short interactive video game device is associated with performance on standard measures of attention and problem solving in patients with systemic lupus erythematosus(SLE). The study is also designed to see if playing the video game for four weeks improves attention and problem solving in patients with SLE.

Eligible Conditions
  • Systemic Lupus Erythematosus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Digit Symbol Substitution Scores
Change in Digit Vigilance Test Scores
Change in EVO performance threshold
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Project EVO Multi- TreatmentExperimental Treatment1 Intervention
Treatment group receives video game device treatment. Participant plays the game for 30 minutes a day, at least five days a week for four weeks.
Group II: ControlActive Control1 Intervention
No contact control

Find a Location

Who is running the clinical trial?

National Jewish HealthLead Sponsor
140 Previous Clinical Trials
316,176 Total Patients Enrolled
Akili Interactive Labs, Inc.Industry Sponsor
15 Previous Clinical Trials
5,105 Total Patients Enrolled
Novartis PharmaceuticalsIndustry Sponsor
2,855 Previous Clinical Trials
4,197,293 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025